Detalhe da pesquisa
1.
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
J Hepatol
; 78(2): 343-355, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309131
2.
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma.
Gut
; 70(1): 157-169, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32217639
3.
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.
Gastroenterology
; 157(2): 537-551.e9, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30978357
4.
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Gastroenterology
; 156(8): 2313-2329.e7, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836093
5.
Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux.
Gut
; 66(5): 896-907, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609828
6.
Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
J Virol
; 90(14): 6387-6400, 2016 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27147737
7.
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
JCI Insight
; 7(13)2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35801591
8.
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.
Sci Transl Med
; 14(676): eabj4221, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542691
9.
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
Nat Commun
; 12(1): 5525, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535664
10.
Interleukin-32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance.
Hepatol Commun
; 3(9): 1205-1220, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31497742